Showing results (71-80 of 180) with videos related to
Sort By:
Pageof 18
Plos One|May 30, 2013
The role of osteocytes in targeted bone remodeling: a mathematical modelJason M Graham, Bruce P Ayati, Sarah A Holstein, et al.Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|February 9, 2000
[Graves ophthalmopathy and ocular myasthenia]A Widjaja, J Rademaker, C Gölkel, et al.Bioorganic & Medicinal Chemistry Letters|November 9, 2019
Novel benzimidazole phosphonates as potential inhibitors of protein prenylationNazmul H Bhuiyan, Michelle L Varney, David F Wiemer, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 6, 2015
Management of relapsed multiple myeloma after autologous stem cell transplantSarah A Holstein, Paul G Richardson, Jacob P Laubach, et al.Survey of Ophthalmology|June 22, 2005
You are what you eatSonalee Kulkarni, Andrew G Lee, Sarah A Holstein, et al.Molecules (Basel, Switzerland)|May 31, 2017
Recent Advances in the Development of Mammalian Geranylgeranyl Diphosphate Synthase InhibitorsStaci L Haney, Veronica S Wills, David F Wiemer, et al.La Revue De Medecine Interne|April 24, 2010
[Tropical pneumonia: pulmonary melioidosis]L Guilleminault, A Holstein, M Azzouz, et al.Bioorganic & Medicinal Chemistry Letters|May 4, 2015
N-Oxide derivatives of 3-(3-pyridyl)-2-phosphonopropanoic acids as potential inhibitors of Rab geranylgeranylationXiang Zhou, Ella J Born, Cheryl Allen, et al.Oncotarget|November 24, 2015
Mechanisms for autophagy modulation by isoprenoid biosynthetic pathway inhibitors in multiple myeloma cellsKaitlyn M Dykstra, Cheryl Allen, Ella J Born, et al.Expert Review of Anticancer Therapy|October 10, 2019
The evolving role of maintenance therapy following autologous stem cell transplantation in multiple myelomaAlmuth Maria Anni Merz, Maximilian Merz, Jens Hillengass, et al.Pageof 18